Alteplase for ischaemic stroke--responses
Lancet
.
2014 Aug 23;384(9944):660-1.
doi: 10.1016/S0140-6736(14)61386-6.
Authors
Peter Sandercock
1
,
Richard Lindley
2
,
Joanna M Wardlaw
3
,
Gordon Murray
3
,
Will Whiteley
3
,
Geoff Cohen
3
Affiliations
1
University of Edinburgh, Edinburgh EH42XU, UK. Electronic address: peter.sandercock@ed.ac.uk.
2
Sydney Medical School-Westmead Hospital and The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.
3
University of Edinburgh, Edinburgh EH42XU, UK.
PMID:
25152266
DOI:
10.1016/S0140-6736(14)61386-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Brain Ischemia / drug therapy*
Fibrinolytic Agents / therapeutic use*
Humans
Stroke / drug therapy*
Tissue Plasminogen Activator / therapeutic use*
Substances
Fibrinolytic Agents
Tissue Plasminogen Activator
Grants and funding
G0400069/MRC_/Medical Research Council/United Kingdom
G0902303/MRC_/Medical Research Council/United Kingdom